WELLS FARGO & COMPANY/MN
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$415,307
+$282,845 QoQ
Shares Held
41,908
+93.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. DNA ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in DNA
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415,307 | 41,908 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $132,462 | 21,609 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $433,241 | 52,135 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $465,101 | 31,900 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $307,754 | 27,356 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,789 | 2,244 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,849 | 392 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,182 | 636 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 DNABW | — | 3 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $17,014 | 50,947 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 DNABW | — | 4 | Shares | Defined | 2024-05-10 | |
| 2024-03-31 | $95,056 | 81,946 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $127,464 | 75,423 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $167,968 | 92,801 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $161,383 | 86,766 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 DNABW | — | 200 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $83,543 | 62,816 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 DNABW | — | 200 | Shares | Defined | 2023-02-13 | |
| 2022-12-31 | $81,953 | 48,494 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 DNABW | — | 200 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $163,169 | 52,298 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 DNABW | — | 200 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $107,486 | 45,163 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 DNABW | — | 240 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $133,888 | 33,223 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 DNABW | — | 240 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $1,618,046 | 194,711 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 DNABW | — | 300 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $252,662 | 21,800 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||